FDA BAA FY26C1CP13 3-year firm-fixed price (FFP) contract for investigating the impact of diastereomers and synthesis-related impurities on the immunogenicity of oligonucleotides.
Active Definitive Contract Awarded Last action
- Contract number
- 75F40126C00087
- Awardee
-
University Of Connecticut UEI WNTPS995QBM7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,173,033
Award facts
- Opportunity
-
- FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Special Notice · FDABAA2600123 · Posted Nov 21, 2025
- Contract value 48% obligated
-
- $1,173,033.00 Current, with exercised options
- $2,432,643.00 Potential, with all options
- Completion date 2% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Storrs, CT 06269, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $2.432 million definitive contract to the University of Connecticut for investigating the impact of diastereomers and synthesis-related impurities on the immunogenicity of oligonucleotides on September 30, 2026, under a firm fixed-price structure.
This award is a three-year effort originating from the FY26 FDA Broad Agency Announcement for Advanced Research and Development of Regulatory Science, which solicits basic and applied research to advance scientific knowledge in regulatory science across FDA-regulated domains. The work is classified under NAICS 541714 (Research and Development in Biotechnology) and PSC code AJ11. Performance occurs in Storrs, Connecticut, with an ultimate completion date of September 29, 2029.
The contract represents research advancement in analytical and computational methods supporting FDA's mission to modernize product development and evaluation. No set-aside restrictions apply to this award.
Quick answers
Who was awarded contract 75F40126C00087?
75F40126C00087 was awarded to University Of Connecticut by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.
How much is contract 75F40126C00087 worth?
The government has obligated $1,173,033 on 75F40126C00087. Its potential value, with all options, is $2,432,643.
Was contract 75F40126C00087 competed?
The extent of competition for 75F40126C00087 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award